Press Release New to The Street Show #780 Premieres Tonight on Bloomberg Television with Robo.ai, American Fusion, Stewards Investment Capital and FreeCast New to The Street · 4 hours ago
Press Release Novo’s Wegovy® was associated with a reduction in food noise according to real-world studies at ObesityWeek® 2026 NOVO NORDISK INC. · 4 hours ago
Press Release ‘A Great Awakening’ actor Jonathan Blair comes home to star in California Baptist University’s ‘A CBU Christmas’ Written By: EIN Presswire · 4 hours ago
Press Release Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting Business Wire · 4 hours ago
Press Release VedaBio Demonstrates Under-10-Minute Molecular Detection with Target Amplification-Free CRISPR Technology at AMP 2026 Business Wire · 4 hours ago
Press Release Olympia plumbing contractor White Knight Plumbing earns recognition from Meritly White Knight Plumbing · 4 hours ago
Press Release Inaugural California Renovation Contest Names California’s Top 10 Home Renovation Brands AI Bridge · 4 hours ago
Press Release Semper Tax Relief Publishes New Guide Explaining IRS Fresh Start Rules Ahead of 2027 Semper Tax Relief · 4 hours ago
Press Release DR.TYPL Lightweight Luminous Serum: Breaking Technical Barriers for At-Home Regenerative Skincare and Setting New Benchmarks in Gentle Anti-Aging Guangzhou Pifu Zhenhao Information Technology Co., Ltd. · 4 hours ago
Press Release Target AI Leads Identifies the Workflow Gaps Costing Australian Law Firms Qualified Clients in 2027 Target AI Leads · 4 hours ago
Press Release New Book Beyond the Classroom By Rob Gowen Helps Parents Navigate Education, Career Choices, and Life After High School BookBuzz · 4 hours ago
Press Release New Literary Historical Novel, In the Day of the Lion Brings Old Europe to Life as Book Two of Stephen Thomas’s Four Lights Series BookBuzz · 4 hours ago
Press Release Novo’s investigational CagriSema, a GLP-1 and amylin analog, demonstrated ~21% average weight loss with lower doses in the REDEFINE 9 trial, presented at ObesityWeek® 2026 and published in The Lancet Diabetes & Endocrinology NOVO NORDISK INC. · 4 hours ago